Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFX.L Regulatory News (AFX)

  • There is currently no data for AFX

Board Appointment

7 Oct 2021 07:00

RNS Number : 2774O
Alpha FX Group PLC
07 October 2021
 

7 Oct 2021

 

Alpha FX Group plc

("Alpha FX" or the "Group")

Board Appointment

 

Alpha FX Group plc (AIM: AFX), a provider of FX risk management and alternative banking solutions to corporates and institutions internationally, is pleased to announce that its Chief Risk Officer, Tim Butters, will today be formally appointed to the Board.

 

Tim joined Alpha from WorldFirst in 2019 with over fifteen years' experience in risk management, including as Head of Risk at World First, the global payments provider, and Mako Trading, a leading derivatives market maker. Since joining Alpha, Tim has been instrumental in defining and building out our Risk Management framework, as well as growing and leading a team that is driving a robust risk culture throughout the business.

 

Commenting on the appointment, Morgan Tillbrook CEO of Alpha FX said:

 

"I am delighted to welcome Tim to the Board. Under his stewardship, the Group is in a very experienced and diligent set of hands, and from day one he has shown he is deeply invested in the long-term growth of the business and ensuring we have a leading risk framework that supports this. I have thoroughly enjoyed working with him over the past few years, and look forward to having him working more closely with the Board and me moving forward."

 

In accordance with Schedule 2(g) of the AIM Rules, Timothy Nigel Butters (aged 39) holds or has held Directorships and Partnerships with the following companies:

 

Current Directorships

 

Past Directorships held in the past five years

 

Alpha FX Limited

Alpha FX Institutional Limited

None

Tim Butters holds 103 shares in Alpha FX Group Limited which are convertible into shares of Alpha FX Group PLC and vest in 2022-2025 as part of the Company's E Share Growth Scheme.

 

Enquiries:

Alpha FX Group plc via Alma PR

Morgan Tillbrook, Founder and CEO

Tim Kidd, CFO

 

Liberum Capital Limited (Nominated Adviser and Sole Broker) Tel: +44 (0) 20 3100 2000 

Neil Patel

Cameron Duncan

Kane Collings

 

Alma PR (Financial Public Relations) Tel: +44 0203 405 0205

Josh Royston

Andy Bryant

Kieran Breheny

 

Notes to Editors

Alpha provides FX risk management and alternative banking solutions to corporates and institutions across the UK, Europe and Canada. Combining leading expertise and technology, the Group partners with a small number of high value clients to provide enterprise-level solutions across four key areas: FX risk management, international payments, accounts and collections. Since it was incorporated in 2010, Alpha FX has been able to build and retain a high-quality client base that includes a number of highly respected brands. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVQLFBFBLEFBQ
Date   Source Headline
19th Dec 20224:02 pmRNSName Change to Alpha Group International
16th Dec 20227:00 amRNSUpdate on Name Change
22nd Nov 20222:04 pmRNSHolding(s) in Company
22nd Nov 202211:00 amRNSResult of General Meeting
10th Nov 20224:53 pmRNSHolding(s) in Company
4th Nov 20227:00 amRNSNotice of GM
4th Nov 20227:00 amRNSF Share Award
26th Oct 20224:22 pmRNSHolding(s) in Company
25th Oct 20225:47 pmRNSHolding(s) in Company
21st Oct 20227:00 amRNSTrading Update
19th Oct 20224:30 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSAppointment of CFO
18th Oct 20225:41 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSLaunch of New Website
14th Sep 20228:17 amRNSDirector/PDMR Shareholding
12th Sep 20225:20 pmRNSDirector/PDMR Shareholding
5th Sep 20227:00 amRNSInterim Report
21st Jul 20227:00 amRNSTrading Update
30th Jun 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSGrowth Share Schemes and PDMR Dealing
6th Jun 20224:18 pmRNSHolding(s) in Company
31st May 20227:00 amRNSTotal Voting Rights
27th May 20224:25 pmRNSHolding(s) in Company
20th May 20224:56 pmRNSHolding(s) in Company
9th May 20223:51 pmRNSDirector/PDMR Shareholding
5th May 202211:27 amRNSResult of AGM
3rd May 20227:00 amRNSTotal Voting Rights
20th Apr 20222:21 pmRNSDirector/PDMR Shareholding
12th Apr 20227:00 amRNSNotice of AGM & Posting of Annual Report
6th Apr 20225:53 pmRNSHolding(s) in Company
6th Apr 20227:00 amRNSPDMR Shareholding
5th Apr 20227:00 amRNSTrading with Key Norwegian Client Recommences
31st Mar 20227:00 amRNSTotal Voting Rights
22nd Mar 20222:24 pmRNSHolding(s) in Company
22nd Mar 20227:00 amRNSBlock Admission Application
16th Mar 20224:13 pmRNSDirector/PDMR Shareholdings
16th Mar 20224:07 pmRNSIssue of Shares, Director/PDMR Shareholdings, TVR
16th Mar 20222:06 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
16th Mar 20229:05 amRNSSecond Price Monitoring Extn
16th Mar 20229:00 amRNSPrice Monitoring Extension
16th Mar 20227:00 amRNSFull Year Results
14th Feb 20221:52 pmRNSHolding(s) in Company
10th Feb 20224:41 pmRNSSecond Price Monitoring Extn
10th Feb 20224:35 pmRNSPrice Monitoring Extension
10th Feb 20222:05 pmRNSSecond Price Monitoring Extn
10th Feb 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSTrading Update and Intended Board Change
13th Jan 20227:00 amRNSAppointment of MD for new Luxembourg office
23rd Dec 20217:00 amRNSRevision to APS Employee Share Ownership Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.